XML 15 R3.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 37,853,947 $ 48,251,336
Marketable securities 15,014,750 0
Accounts receivable 13,327,364 8,910,975
Prepaid expenses and other current assets 2,962,903 1,936,842
Total current assets 69,158,964 59,099,153
Non-current assets    
Property and equipment, net 78,107 171,190
Right of use assets - operating leases 999,567 278,455
Patents and patent applications, net 11,628 13,000
Other non-current assets 179,532 1,051,234
Total assets 70,427,798 60,613,032
Current liabilities    
Accounts payable and accrued liabilities 3,369,848 2,966,479
Accrued salaries and wages 201,254 908,516
Royalty payable 2,920,148 1,908,072
Deferred revenue 16,618 354,756
Operating leases - current 337,690 282,421
Total current liabilities 6,845,558 6,420,244
Long-term liabilities    
Operating leases - long term 673,347 0
Convertible debt, net of unamortized discount 16,069,085 18,700,546
Total liabilities 23,587,990 25,120,790
Stockholders' equity    
Common stock; par value $0.001; 200,000,000 shares authorized; 4,909,846 and 4,258,105 shares issued and outstanding at December 31, 2021 and 2020, respectively. 4,910 4,259
Additional paid-in capital 108,569,988 100,203,979
Accumulated other comprehensive loss (54,815) (26,931)
Accumulated deficit (61,680,275) (64,689,065)
Total stockholders' equity 46,839,808 35,492,242
Total liabilities and stockholders' equity $ 70,427,798 $ 60,613,032